Upgrade to SI Premium - Free Trial

TD Cowen on Boston Scientific (BSX): 'We Expect a Strong 2Q'

July 21, 2025 10:09 AM
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $115.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles